Reinforcement of poly-L-lactic acid electrospun membranes with strontium borosilicate bioactive glasses for bone tissue engineering by Fernandes, João S. et al.
Acta Biomaterialia 44 (2016) 168–177Contents lists available at ScienceDirect
Acta Biomaterialia
journal homepage: www.elsevier .com/locate /ac tabiomatFull length articleReinforcement of poly-L-lactic acid electrospun membranes with
strontium borosilicate bioactive glasses for bone tissue engineeringhttp://dx.doi.org/10.1016/j.actbio.2016.08.042
1742-7061/ 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
⇑ Corresponding authors at: 3B’s Research Group – Biomaterials, Biodegradables
and Biomimetics, University of Minho, Headquarters of the European Institute of
Excellence on Tissue Engineering and Regenerative Medicine, AvePark, 4806-909
Taipas, Guimarães, Portugal (R.A. Pires).
E-mail addresses: rpires@dep.uminho.pt (R.A. Pires), paul.hatton@sheffield.ac.uk
(P. Hatton).João S. Fernandes a,b, Piergiorgio Gentile c, Margarida Martins a,b, Nuno M. Neves a,b, Cheryl Miller c,
Aileen Crawford c, Ricardo A. Pires a,b,⇑, Paul Hatton c,⇑, Rui L. Reis a,b
a 3B’s Research Group – Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering
and Regenerative Medicine, AvePark, 4806-909 Taipas, Guimarães, Portugal
b ICVS/3B’s – PT Government Associate Laboratory, Braga/Guimarães, Portugal
cCentre for Biomaterials and Tissue Engineering, School of Clinical Dentistry, University of Sheffield, Claremont Crescent, Sheffield S10 2TA, United Kingdom
a r t i c l e i n f o a b s t r a c tArticle history:
Received 7 June 2016
Received in revised form 8 August 2016
Accepted 19 August 2016






BM-MSCsHerein, for the first time, we combined poly-L-lactic acid (PLLA) with a strontium borosilicate bioactive
glass (BBG-Sr) using electrospinning to fabricate a composite bioactive PLLA membrane loaded with
10% (w/w) of BBG-Sr glass particles (PLLA-BBG-Sr). The composites were characterised by scanning
electron microscopy (SEM) and microcomputer tomography (l-CT), and the results showed that we suc-
cessfully fabricated smooth and uniform fibres (1–3 lm in width) with a homogeneous distribution of
BBG-Sr microparticles (<45 lm). Degradation studies (in phosphate buffered saline) demonstrated that
the incorporation of BBG-Sr glass particles into the PLLA membranes increased their degradability and
water uptake with a continuous release of cations. The addition of BBG-Sr glass particles enhanced the
membrane’s mechanical properties (69% higher Young modulus and 36% higher tensile strength).
Furthermore, cellular in vitro evaluation using bone marrow-derived mesenchymal stem cells
(BM-MSCs) demonstrated that PLLA-BBG-Sr membranes promoted the osteogenic differentiation of the
cells as demonstrated by increased alkaline phosphatase activity and up-regulated osteogenic gene
expression (Alpl, Sp7 and Bglap) in relation to PLLA alone. These results strongly suggest that the compos-
ite PLLA membranes reinforced with the BBG-Sr glass particles have potential as an effective biomaterial
capable of promoting bone regeneration.
Statement of Significance
PLLA membranes were reinforced with 10% (w/w) of strontium-bioactive borosilicate glass microparti-
cles, and their capacity to induce the osteogenic differentiation of bone marrow mesenchymal stem cells
(BM-MSCs) was evaluated. These membranes presented an increased: degradability, water uptake, Young
modulus and tensile strength. We also demonstrated that these membranes are non-cytotoxic and
promote the attachment of BM-MSCs. The addition of the glass microparticles into the PLLA membranes
promoted the increase of ALP activity (under osteogenic conditions), as well as the BM-MSCs osteogenic
differentiation as shown by the upregulation of Alpl, Sp7 and Bglap gene expression. Overall, we demon-
strated that the reinforcement of PLLA with glass microparticles results in a biomaterial with the
appropriate properties for the regeneration of bone tissue.
 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.1. Introduction
The development of biomaterials for guided bone tissue
engineering (BTE) has been a hot topic of research in recent years.
Biomaterials can act as a short-term template in which cells prolif-
erate and deposit extracellular matrix (ECM), helping bone
ingrowth as a part of its regeneration process. A suitable biomate-
rial for BTE should present appropriate mechanical properties that
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site and to support cell ingrowth as part of the bone formation pro-
cess. The capacity to shape the biomaterial substrate to fit exactly
in the bone lesion is of particular relevance, too [1,2].
Electrospinning is a versatile technique that applies electro-
static forces to manufacture ultrathin fibre meshes from melted
polymers or polymer solutions. This methodology has been used
to obtain biomaterials composed by micro- or nano-fibres with
high surface areas and mechanical properties suitable for BTE by
playing with its different processing parameters [2,3]. Further-
more, electrospun membranes closely mimic the ECM promoting
cell attachment and proliferation [4].
Poly-L-lactic acid (PLLA) is a biodegradable and biocompatible
polymer, widely investigated for BTE, specially due to the approval
of different PLLA medical devices for clinical use by the US Federal
Food and Drug Administration (FDA) [5]. Furthermore, PLLA has
appropriate flexibility and deformation capacity, and can be pro-
cessed by different techniques (e.g. melt, dry and wet spinning,
as well as electrospinning) [6–9]. However, PLLA is not commonly
considered osteoinductive [4,10]. Thus, in order to improve the
biological performance of PLLA fibres, the polymeric matrix can
be combined with inorganic materials, such as bioactive glasses
(BGs) and glass-ceramics, improving its osteoinductive potential
[11,12]. Moreover, the PLLA degradation rate can be shaped by sev-
eral different variables (e.g. chemical structure and crystallinity of
the polymer, size and shape of the final material), although, the
matching of the rate of degradation and the kinetics of the
formation of new bone tissue is still difficult to achieve [13,14].
The addition of an inorganic phase allows a better control of the
degradation rate of the final PLLA-glass composite, which can
be used to manufacture a composite with a suitable degradation
rate while progressively being substituted by the new bone that
is being formed [15].
BGs are a group of inorganic bioactive materials that are able to
form a bone-like hydroxyapatite (HA) layer on their surface cap-
able to strongly bond to hard and soft tissues [11,16–18]. Immedi-
ately after the launch of the 45S5 Bioglass in the market (chemical
composition by mol: 0.45SiO20.06P2O50.245Na2O0.245CaO) it
became the gold standard for bioactive glass materials [16]. Subse-
quently, a wide range of BGs based on the 45S5 composition have
been developed and studied for BTE [19,20]. The addition of borate
glass forming units is one approach that has potential to lower
melting temperatures while controlling bio-degradation and
increasing conversion rates to HA [21,22]. Borosilicate-based BGs
(BBGs) have been previously studied as biomaterials and have
shown relevant capacity as osteointegrative antibacterial materials
to be used in BTE [23,24]. BBGs have been also incorporated into
scaffolds: Wang et al. [25] successfully incorporated copper doped
borosilicate glasses (BBGs-Cu) into a polymeric scaffold for
tissue engineering purposes. They observed an improvement in
the stability of the glass network and the BBGs-Cu promoted the
angiogenesis in rat calvarial defects.
Moreover, in our previous studies we tested a BBG glass
composition (e.g. molar ratio: BBG-Sr: 0.05Na2O0.35SrO0.20B2O3
0.40SiO2) for their osteogenic capacity. We found that the presence
of BBG-Sr glass particles improved the osteogenic differentiation of
bone marrowmesenchymal stem cells (BM-MSCs) and induced the
formation of mineralised tissue. We also demonstrated that
BBG-Sr, at concentrations P18 mg/mL it was able to eradicate
Pseudomonas aeruginosa bacterium [26]. Numerous reports have
already associated Sr2+ with bone therapeutic potential [19].
Depending on the concentration, Sr2+ can exerts many effects on
bone metabolism at the tissue and cellular levels as well as in bone
formation in vivo [27,28]. For instance, Marie et al. [27] demon-
strated strontium modulates bone cell function (e.g. cell prolifera-
tion and differentiation) in vitro stimulating bone formation andinhibiting bone resorption. Moreover, Hesaraki et al. showed that
glasses doped with strontium promoted osteoblast proliferation
and ALP activity when directly in culture with cells [29]. For
instance, Wu et al. [30] developed a strontium silicate glass which
promoted a high ALP activity in BM-MSC cell culture, that was
associated with the release of Sr2+ and silica. Also, Santocildes-
Romero et al. [31] demonstrated that strontium-substituted
bioactive glasses promoted osteogenic differentiation of BM-MSCs
cultures in the presence of strontium – containing BGs. They showed
an increased expression of genes such as Alpl and Bglap. Moreover,
Gentleman et al. [32] studied the effect of the release of Si- and
Sr-related chemical entities from PCL-SrBG scaffolds, and they
detected that the SrBG particles stimulated osteoblast proliferation
and ALP activity in relation to the SrBG-free PCL scaffold. Moreover,
BM-MSCs are of special interest due to their capacity to differentia-
tion into different lineages (including osteoblastic cells) with
appropriate external stimuli and the fact that it is relatively easy to
isolate [33]. For that reason, BM-MSCs have received extensive
attention as promoters of tissue regeneration.
To our knowledge, the PLLA-BBG-Sr composite membranes
fabricated by electrospinning has not been achieved to-date.
Therefore, we aimed to evaluate the potential of PLLA-BBG-Sr
composite membranes for BTE and bone regeneration. Herein, we
investigated the impact of the incorporation of BBG-Sr glass parti-
cles in PLLA fibre meshes on their tensile strength and degradation.
Moreover, we evaluated the response of BM-MSCs in the presence
of PLLA-BBG-Sr fibres, namely in what regards their morphology,
proliferation and ability to induce its differentiation.2. Experimental
2.1. Materials
All chemicals used for the melt-quenched synthesis were
reagent grade: boron oxide (B2O3, Alfa Aesar, Germany), calcium
carbonate (CaCO3, Sigma-Aldrich, UK), sodium bicarbonate
(NaHCO3, Sigma-Aldrich, Australia), silica gel 60 M (SiO2,
Macherey-Nagel, Germany), magnesium oxide (MgO, Sigma-
Aldrich, UK) and strontium carbonate (SrCO3, Sigma-Aldrich,
Australia). All the chemical reagents used for electrospinning were
reagent grade: PLLA with a L-lactide content of 99.6% and an aver-
age Mw of 69,000 gmol1 (Cargill Dow LLC, USA), dichloromethane
(Sigma-Aldrich, UK), and the anionic surfactant docusate sodium
salt (Sigma-Aldrich, UK).
The BBGs were produced as described elsewhere [34]. Briefly,
the appropriate amounts of SiO2, B2O3, NaHCO3, and CaCO3 or
MgO or SrCO3, were accurately mixed with ethanol (Sigma,
Portugal) in a porcelain pestle and mortar, fully dried overnight
and transferred to a platinum crucible (ZGS platinum, Johnson
Matthey, UK). Each batch (50 g) was heated to 1450 C in air
for 1 h and, subsequently, the melt was quickly poured into an
ice-water bath at 0 C to form a glass frit. Afterwards, the glasses
of general formula 0.05Na2OxMgOyCaO(0.35-x-y)SrO0.20B2O3
0.40SiO2 (molar ratio, where x, y = 0.35 or 0.00, and x– y) were
ground into an Agate mortar (RETSCH, Germany) to obtain
microparticles and sieved to a size <45 lm to be homogeneously
incorporated in the polymeric matrix during the fabrication of
the fibres. The density of the BBGs was measured by a Multi
pycnometer (Quantachrome Instruments, USA) under helium at
110 C using 5 g of each sample.2.2. Membranes preparation
PLLA-BBG-Sr membranes were fabricated by electrospinning
inside a fume hood cabinet for safe solvent evaporation and in
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of the fibres. The PLLA concentration, the ratio of PLLA/ BBG-Sr
and the process parameters (e.g. applied voltage, flow rate and dis-
tance from the collector) were optimized in order to obtain uni-
form membrane of fibres. The final electrospun membranes were
fabricated using PLLA dissolved in dichloromethane (16% w/v)
where the BBGs microparticles were suspended (10% w/w BBGs/
PLLA). Docusate sodium salt (1.2% w/w relative to PLLA) was used
to help the homogenization of the solution avoiding the formation
of agglomerates. The PLLA and PLLA-BBG-Sr solutions were stirred
overnight and sonicated 5 min before use to remove air bubbles.
The set up was mounted using a high voltage supplier, a syringe
pump (Baxter AS50) with a 20 gauge metal needle (Fisnar, New
Jersey, USA) and a conductive collector. The PLLA and PLLA-BBG-Sr
solutions were drawn up into a 1ml syringe (BD Plastipak, New
Jersey, USA). The solutions were electrospun using 17 kV and a flow
rate of 3 mL/h at a 19 cm distance between the collector and needle.
The electrospun membranes were dried in a fume hood, at room
temperature, for 24 h, collected and stored in a desiccator at room
temperature.
2.3. Characterisation of electro-spun membranes
2.3.1. Scanning electron microscopy (SEM)
The Scanning Electron Microscopy (Leica Cambridge S360
microscope, equipped with an energy dispersive spectrometer,
UK) was used to assess the surface morphology of the fabricated
PLLA and PLLA-BBG-Sr membranes. Prior to the analysis, all the
scaffolds were sputter-coated with gold. The micrographs were
acquired using a beam energy of 5.0 kV and working distance of
5.2 mm.
2.3.2. Micro-computed tomography (lCT)
Micro-computed tomography (l-CT) was carried out on a high-
resolution l-CT scanner (SkyScan1272, Bruker, Kontich, Belgium),
using a pixel size of 9.8 lm and integration time of 160 ms. The
X-ray source was set at 50 kV of energy and 200 lA of current.
Approximately 400 projections were acquired over a rotation range
of 180 with a rotation step of 0.60. Data sets were reconstructed
using standardised cone-beam reconstruction software (NRecon
v1.6.10.2, SkyScan). The output format for each sample was a series
of 601 bitmap images (1224  1224 pixels). 3D virtual models of
representative regions in the bulk of the scaffolds were created
applying colour channel thresholds and visualised using an image
processing software (CTvox).
2.3.3. Mechanical tests
Tensile strength and modulus of the PLLA and PLLA-BBG-Sr
membranes were measured using a Uniaxial Universal Testing
Machine (Instron 4505, USA) according to the standard ASTM D
638. The membranes were cut into strips of 50 mm length,
10 mm width and 0.1 mm thickness. The tests were conducted
using a 1 kN load cell, with a gauge length of 20 mm and a cross-
head speed of 5 mmmin1 until rupture. The tensile force was
taken from the stress–strain curves as the maximum stress hold
by the samples. Tensile modulus was estimated from the initial
slope of the stress–strain curve (between 0.5% and 1% strain) using
the linear regression method. The average and standard deviations
were determined using 5 specimens per composition.
2.3.4. Degradation assay
The electrospun membranes (n = 3 per time point) were
immersed in PBS (Sigma-Aldrich, UK) at a ratio of 10:10
(membrane (mg): PBS (mL)) for 7, 14, 21, and 28 days in a water-
shaking bath at 60 rpm and 37 C. Each immersion solution was fil-
tered and the pH measured (Crison Instruments, Spain). Inductivecoupled plasma (ICP) analysis was performed to determine the
concentrations of Si, B and Sr in solution. The absorption was mea-
sure at specific wavelengths (k = 251.611 nm for Si, k = 249.773 nm
for B and k = 407.771 nm for Sr) and the concentrations were
determined using calibration curves obtained with standard
solutions (Alfa Aesar) prior to the analysis of the samples.
The membranes were removed from PBS, the excess surface
water was removed and the samples were immediately weighed.
Afterwards, the samples were dried in the oven at 37 C, to con-
stant weight, recording the final mass of the membranes. The
water uptake (WU) was calculated according to Eq. (1):
WU ð%Þ ¼ ðmtp mf Þ=mf  100 ð1Þ
where mtp is the wet mass of the specimen at the specific time
(days), and mf is the final mass after immersion and drying. The
weight loss (WL) was calculated according to Eq. (2):
WL ð%Þ ¼ ðmf miÞ=mi  100 ð2Þ
where mf is the mass of the dried membranes after its immersion in
water, and mi is the mass of the dried membranes before immersion
in PBS.
Thermogravimetric analysis (TGA; Q500, TA Instruments, USA)
was also used to quantify the changes in the weight (mass) of
the membranes during the degradation process. In addition,
thermal analysis was performed to determine the amount of
BBG-Sr (non-combustible) glass particles that was compounded
with PLLA to produce the composite membranes. Experiments
were performed in platinum pans, at a heating rate of 40 Kmin1
from 50 to 700 C in an oxygen atmosphere.
2.4. In vitro culture of BM-MSCs on electrospun membranes
2.4.1. Isolation and expansion of BM-MSCs
Bone marrow mesenchymal stem cells (BM-MSCs) were iso-
lated from bone marrow of 4–5 week-old male Wistar rats
according to the method established by Maniatopoulos et al. [35]
and recently used by Santocildes-Romero [31]. BM-MSCs were
expanded in basal medium consisting of Dulbecco’s modified
Eagle’s medium (DMEM; Sigma-Aldrich, UK), supplemented with
100 U/mL penicillin (Sigma-Aldrich, UK) and 100 lg/mL strepto-
mycin (Sigma-Aldrich, UK). Cells were cultured at 37 C in an
atmosphere of 5% CO2.
2.4.2. Culture of BM-MSCs
Prior to the in vitro studies, BM-MSCs, at passage 2, were
harvested and seeded at a density of 3  104 cells per membrane
of Ø = 6.5 mm held in plastic inserts (CellCrownTM 24, Scaffdex,
UK). Cells were cultured for 7, 14 and 21 days under static
conditions. All scaffold conditions were cultured in basal and
osteogenic differentiation media (basal medium supplemented
with 50 lg/mL L-ascorbic acid, 10 mM b-glycerophosphate and
108 M dexamethasone).
2.4.3. BM-MSCs proliferation, viability and morphology
2.4.3.1. Morphological evaluation of cultured cells. After each time-
point the cells cultured on the membranes were washed with
PBS and fixed with 4% formalin solution (0.5 mL) for 15 min at
room temperature (RT). The cells were then washed with PBS, con-
taining 0.2% Triton X, for 2 min. After the fixation and permeation
steps, the cells were washed again with PBS and stained with 4,6-
diamidino-2-phenyindole dilactate (1:1000 DAPI, Sigma-Aldrich,
UK) for 2 min at RT, and phalloidin-tetramethylrhodamine B
isothiocyanate (Sigma-Aldrich, UK) for 1 h at RT. Finally, the cells
were washed and observed using an Axioplan 2 imaging fluores-
cent microscope with a digital camera QIC AM 12-bit (Zeiss, UK).
Table 1
Primers used for qPCR.
Gene Primer sequence 50-30
Forward/ reverse
Tm (C)
Osteocalcin (Bglap) CATCTATGGCACCACCGTTT 60.0
AGAGAGAGGGAACAGGGAGG
Osteopontin (Spp1) ATCTCACCATTCCGATGAATCT 60.0
CAGTCCATAAGCCAAGCTATCA
Osterix (Sp7) CACTGGCTCCTGGTTCTCTC 60.0
CCACTCCTCCTCTTCGTGAG
Alkaline phosphatase (Alpl) TGCCTTACCAACTCATTTGTG 57.4
ACGCGATGCAACACCACTC
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assays). The PrestoBlue reagent (Fisher Scientific, UK) is a
resazurin-based solution that is reduced to resorufin by viable cells
which can be detected fluorometrically. The cell viability assay was
executed according to the manufacturer’s instructions. In brief, the
PrestoBlue reagent was added to a final concentration of 10% to
the cell culture medium and the cultures incubated for 1 h at
37 C. 200 lL samples of the culture medium were removed and
placed in 96-well plates and the resorufin fluorescence quantified
spectrophotometrically using a plate reader (Tecan Infinite
M200). The fluorescence was determined at an excitation wave-
length of 560 nm and emission wavelength of 590 nm. The meta-
bolic activity was presented in fluorescence values and compared
with the control (cell cultured onto PLLA membranes under basal
medium conditions).
The PicoGreen dsDNA reagent (Invitrogen, USA) is an
ultrasensitive fluorescent nucleic acid dye for quantification of
double-stranded DNA (dsDNA) in solution. This assay enables
measurement of cell proliferation. After each culturing period,
the cells were washed with PBS and incubated at 37 C for 3 h
followed by a freezing step at 80 C for overnight in ultra-pure
water (1 mL) to ensure the cell lysis. Finally, the fluorescence
was determined at an excitation wavelength of 485 nm and emis-
sion wavelength of 528 nm. The DNA concentration was presented
in lg/mL and compared with the control (cell cultured onto PLLA
membranes under basal medium conditions).
2.4.4. Alkaline phosphatase quantification
The concentration of alkaline phosphatase (ALP) was deter-
mined for all the cell culture time points, using the lysates used
for the DNA quantification and the Alkaline Phosphatase,
Diethanolamine Detection kit (Sigma-Aldrich, UK), which is based
on the conversion of p-nitrophenyl phosphate (pNPP) to free
p-nitrophenol by ALP. In brief, a buffered pNPP solution was pre-
pared and equilibrated at 37 C. Afterwards, 2% (v/v) of sample or
control lysate was added. Immediately after mixing the absorbance
was read at 405 nm in a plate reader (Tecan Infinite M200) for
5 min. An ALP standard solution was used as control and buffer
as blank. The units were calculated according to the following Eq.
(3):
ðDA405 nm=min Test  DA405 nm=min BlankÞ  df  VF
18:5 VE ð3Þ
where df = dilution factor; VF = Volume of final solution; 18.5 =
millimolar extinction coefficient of pNPP at 405 nm and
VE = Volume of samples/ALP standard solution.
2.4.5. RNA isolation and real-time quantitative polymerase chain
reaction (rtPCR)
RNA was extracted with Tri-reagent (Sigma-Aldrich, UK)
according to the manufacturer’s instructions. The RNA concentra-
tion was determined by microspectrophotometry (NanoDrop
1000). The cDNA synthesis was performed using the qScript cDNA
synthesis kit (Quanta BioSciences, VWR) with 100 ng of RNA tem-
plate in a final volume of 20 lL. Cycling was as follows: 1 cycle at
22 C, 5 min; 1 cycle at 42 C, 30 min; 1 cycle at 85 C, 5 min. The
amplification of the target cDNA was performed using the PerfeCTa
SYBR Green FastMix (Quanta BioSciences) with 1 lL of cDNA, 200
nM of each primer (Table 1) in a final volume of 20 lL. Real
time-PCR cycling was as follows: 1 cycle at 95 C, 2 min; 44 cycles
at 95 C; 10 s at gene annealing temperature (Table 1); 30 s at
72 C; followed by dissociation curve analysis. All the reactions
were carried out on a PCR cycler Mastercycler Realplex (Hamburg,
Germany). The transcripts expression data were normalised to the
housekeeping gene glyceraldehyde-3-phosphate dehydrogenase
(Gapdh) in each sample. The quantification was performedaccording to the Livak method (2DDCt method [36]), considering
as calibrator at each time point the PLLA – basal medium for PLLA
– osteogenic medium and PLLA-BBG-Sr basal medium for
PLLA-BBG-Sr osteogenic medium (threshold = 1).3. Results and discussion
3.1. Characterisation of electrospun membranes
The PLLA and PLLA-BBG-Sr (10% w/w BBG-Sr/PLLA) composite
membranes were successfully obtained by electrospinning. TGA
analysis confirmed that we successfully incorporated 10% (w/w)
of BBG-Sr microparticles in the PLLA fibres. The morphology,
microstructure and fibre integrity of the electrospun PLLA and
PLLA-BBG-Sr membranes was characterised by SEM and lCT. Elec-
trospun PLLA and PLLA-BBG-Sr membranes are composed of
smooth and uniform fibres. No large particles were detected
(Fig. 1a and c), however, the formation of small agglomerates in
the membranes containing the BBG-Sr microparticles was
observed [37]. Fig. 1c highlights in red circles the BBG-Sr micropar-
ticles incorporated into the fibres. The homogeneous distribution
of the BBG-Sr microparticles in the PLLA-BBG-Sr membrane could
be observed in the 2D virtual model representatively obtained
using an image processing software CTvox of lCT images (Fig. 1d),
in which the red colour represents the BBG-Sr microparticles dis-
tributed into the composite membranes in green. As expected,
the PLLA membranes do not present any particles in their structure
(Fig. 1b).
The mechanical properties of the biomaterials are important in
providing physical support for cell growth and migration matching
those of the tissue at the site of implantation [38]. Fig. 2a presents
the stress–strain curves obtained for the PLLA and PLLA-BBG-Sr
membranes under tensile load up to a strain of 50%. The
PLLA-BBG-Sr membranes showed the highest tensile strength
(0.75 ± 0.7 MPa), when compared to the PLLA membranes
(0.55 ± 0.6 MPa), indicating that the incorporation of BBG-Sr rein-
forced the membranes. The same trend was observed for the
Young’s modulus (Fig. 2b), calculated from the initial linear slope
of the stress–strain curves, where the loading of BBG-Sr micropar-
ticles improved the modulus from 14.6 ± 3.8 MPa (PLLA) to
24.7 ± 5.3 MPa (PLLA-BBG-Sr). This might be due to an increase
in rigidity through the filler effect, in which the microparticles
encumber the movement of the polymer chains and the amount
of extendable material in the membrane. On the other hand, while
the incorporation of the microparticles in PLLA-BBG-Sr membranes
can affect the tensile strength, where there is no interaction
between fibres and particles. The availability of cations derived
from the incorporated microparticles may contribute to the
crosslinking of the carboxylic acid groups (that are present in the
chain ends of the PLLA) through the formation of carboxylates.
These carboxylate cross-links induce the interlocking of the
Fig. 1. SEMmicrographs (a and c) and representative lCT 2D images (b and d) of PLLA and PLLA-BBG-Sr membranes. The areas encompassed by red lines in (c) show particles
incorporated into the fibres. In (b and d) PLLA fibres are represented in green and the BBG-Sr microparticles are represented in red. (For interpretation of the references to
colour in this figure legend, the reader is referred to the web version of this article.)
Fig. 2. (a) Stress–strain curves of PLLA and PLLA-BBG-Sr membranes and their
respective (b) Young’s modulus determined from the initial slope of the curves. The
data was analysed by non-parametric statistics; data analysis using the Mann-
Whitney test revealed a significance of p < 0.05 (⁄).
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[39]. As demonstrated by Thomas et al. [40], small concentrations
of nano hydroxyapatite (HA) resulted in a reinforcement of PCL. It
was observed by Jeong et al. [41] in an analogous way, that the
addition of increasing concentrations of HA increasingly enhanced
the mechanical properties of the composite, namely their tensile
strength and Young’s modulus. Therefore, our results support that,
with the inclusion of BBG-Sr microparticles into the PLLA matrix, it
is possible to tune their mechanical properties, contributing to be a
closer match of those from the living tissue at the site of
implantation.3.2. Degradation of the electrospun membranes
A biomaterial suitable for promoting bone regeneration in a
tissue engineering perspective should present an appropriate
biodegradability. The BTE concept is based on the substitution of
the biomaterial by new bone. This requires that the degradation
rate of the biomaterial matches that of new bone formation, in
order to occur a progressive substitution of the biomaterial by
the new bone tissue [15,42]. The degradation profiles of PLLA
and PLLA-BBG-Sr membranes (Fig. 3) were evaluated from the
weight loss and water uptake, as well as the release of chemical
species from the membranes and pH of the immersion solutions.
The water uptake and weight loss data showed differences
between the PLLA and the PLLA-BBG-Sr membranes (Fig. 3b and d).
Both membranes presented steady and continuous water
uptake and weight loss from week 2 to week 3. However, the
PLLA-BBG-Sr membranes presented a more pronounced ‘burst’ of
Fig. 3. Degradation profile of the PLLA and PLLA-BBG-Sr membranes during 30 day of degradation in PBS at 37 C. (a) release profiles of chemical species from the
PLLA-BBG-Sr membranes; (b and d) WU and WL of the PLLA and PLLA-BBG-Sr membranes; and (c) percentage of glass (w/w) in the studied membranes.
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membranes during this initial stage of degradation might be
attributed to the penetration of the PBS solution through the
polymer/glass interface and/or surface cracks that facilitated
the degradation of the material and enhanced the water uptake.
Another possibility is related with a superficial hydrolytic degrada-
tion generated by the leaching of chemical species from the glass
particles [43,44]. The pH measurements presented no significant
variation of pH for both PLLA and PLLA-BBG-Sr membranes over
time. An initial burst release of B, Si and Sr from the PLLA-BBG-Sr
membranes into the immersion solution was observed (Fig. 3a).
The release of such chemical species can only have originated from
the BBG-Sr microparticles, corroborating the possibility of the ori-
gin of the weight loss being mainly derived from the hydrolytic
degradation of the glass particles. During the last week of
degradation (21–28 days) it was also noticed that an increase in
the PLLA-BBG-Sr weight loss that correlates with the reduction of
glass percentage determined by TGA (Fig. 3c) and the increased
concentration of mainly B and Sr-containing chemical species, that
were leached from the glass particles to the immersion medium
(detected by ICP). The increase on the degradation is clear during
the last week; however, the leaching observed by ICP during the
first 3 weeks is not corroborated by the TGA analysis. In this case,
the presence of phosphates from the solution buffer might gener-
ate a surface layer of strontium phosphate that limits the mass
exchange from the glass particles to the immersion solution. In this
case, the weight loss derived from the leaching of B, Si and Sr from
the glass particles is partially compensated by the deposition of
phosphates. The fact that the PLLA-BBG-Sr composite membranes
lost twice the mass during the degradation process suggests thatthe incorporation of BBG-Sr into PLLA fibres increased the degrad-
ability and the degradation rate of the membranes, as well as the
release of active chemical species to the surrounding medium [15].
3.3. In vitro biological evaluation
3.3.1. Morphology, viability and proliferation of the BM-MSCs
Apart from the suitable chemical and physical properties of the
biomaterial, it is also crucial to evaluate if they are cytotoxic. To
this purpose, direct contact assays are widely used as a preliminary
screening for biomaterials [45]. Fluorescence microscopy images
(Fig. 4a) show the morphology of BM-MSCs cultured in the pres-
ence of PLLA and PLLA-BBG-Sr membranes in basal or osteogenic
medium (Fig. 4a, Basal and Osteo, respectively). The attached
BM-MSCs displayed a well-spread morphology and several cell-
to-cell contacts. As expected, the PrestoBlue and PicoGreen data
(Fig. 4b and c) demonstrated that the cells proliferated over the
time course under basal conditions, which is consistent with the
morphology images (Fig. 4a). There is also and increase on their
metabolic activity (day 7 versus day 21). However, under osteo-
genic conditions BM-MSCs did not proliferate and exhibited an
increase in metabolic activity (day 7 versus day 21), which sug-
gested the occurrence of differentiation [8,46]. PLLA and PLLA-
BBG-Sr electrospun membranes were found to be a non-cytotoxic
support for BM-MSCs attachment and proliferation (Fig. 4) without
any adverse effect caused by the addition of BBG-Sr particles. In
addition, the randomly distributed fibres and porous structure of
electrospun membranes should enable an efficient transfer of
nutrients, as well as support suitable cell penetration into the bulk
of the membranes.
Fig. 4. (a) Morphology, (b) metabolic activity and (c) proliferation of BM-MSCs cultured for 7, 14 and 21 days in basal (basal) or osteogenic medium (osteo), and in the
presence of PLLA or PLLA-BBG-Sr. In the representative microscopy images (a) the nuclei of cells are stained in blue (DAPI) and the actin filaments are stained in green
(Phalloidin). In Fig. 4b and c, the results are expressed as means ± standard deviation with n = 3 for each experimental data point. The data were analysed by non-parametric
statistics: Kruskal-Wallis test, followed by a Dunn’s Multiple Comparison test and were marked as: ***p < 0.001; **p < 0.01; *p < 0.05. On the graphs the figure ‘1’ represents the
comparison with day 7 and the figure ‘2’ represents the comparison with day 14. (For interpretation of the references to colour in this figure legend, the reader is referred to
the web version of this article.)
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It has been demonstrated that the release of chemical species
containing Si, B or Sr from BBG-Sr glass particles could stimulate
the osteoblast proliferation and differentiation. The ALP activity
is commonly related with functional activity of the bone-derived
cells, such as their osteogenic differentiation and the onset of min-
eralisation [37,47]. In order to execute a preliminary evaluation on
the capacity of the PLLA-BBG-Sr membranes to induce osteogenic
differentiation, we cultured BM-MSCs onto them and quantified
the ALP activity after 7, 14 and 21 days (Fig. 5b). SEM was also used
to check for mineral deposits and the mineralisation stage of the
BM-MSCs (Fig. 5a). In the SEMmicrographs it is possible to confirm
that the BM-MSCs create a cell layer attached to the PLLA and
PLLA-BBG-Sr membranes. However, in the case of BM-MSCs cul-
tured under osteogenic conditions, formation of phosphate
deposits at the later time points (Fig. 5a, day 21) were observed.
In contrast, ALP activity (Fig. 5b) increased during the time of cul-
ture under osteogenic conditions, suggesting that the addition of
BBG-Sr microparticles increased the ALP expression levels.
Therefore, the PLLA-BBG-Sr membranes stimulated the BM-MSCs
to initiate their osteogenic differentiation. This stimulus is very
likely to be related with the presence of the B, Si and Sr chemical
species leaching from the BBG-Sr glass particles to the surrounding
medium [48,49], as also shown in the ICP data (Fig. 3a). Compara-
tively, some authors [31,32] studied the effect of the release of Si
and Sr chemical species from BG, and found that they stimulate cell
differentiation. Other authors have also demonstrated improvementsin cell differentiation and bone mineralisation by the addition of
glass particles into polymeric matrices [6,37,50]. As an example,
Santocildes-Romero [9], fabricated electrospun membranes incor-
porating 10% BGSr glass particles with increasing Sr content with
no cytotoxic effects on osteosarcoma cells; Rajzer and co-workers
[37] verified that the addition of 20% hydroxyapatite ceramic
particles into PLDL electrospun composites could direct HAp min-
eralisation in cell culture; Ren et al. [6] also showed that PCL-SrBG
electrospun scaffolds enhanced the ALP activity of MC3T3-E1 cells
in the presence of osteogenic media in comparison with the
glass-free PCL scaffolds after 21 days of culture. Hence, the addi-
tion of BBG-Sr glass particles to PLLA fibres accelerated the
BM-MSCs osteogenic differentiation (ALP activity, Fig. 5a), in the
presence of osteogenic media after 14 days of cell culture, showing
an higher increase after 21 days of cell culture.
Complementary to the reported viability, proliferation and ALP
activity data, the differentiation level of BM-MSCs cultured onto
PLLA and PLLA-BBG-Sr membranes was assessed by quantitative
PCR of selected bone-specific gene transcripts. In the literature it
is well described that osteogenic differentiation of BM-MSCs has
three phases: the proliferative phase, which is followed by the
ECM synthesis and maturation, and lastly the mineralisation phase
[51,52]. Therefore, in this study the osteogenic potential of the cells
was evaluated at day 14 and 21 using the expression pattern of the
representative osteogenic markers: Alpl, Spp1, Bglap and Sp7 [8,53].
The transcripts expression data were normalized against the
housekeeping gene Gapdh and the quantification performed
according to the Livak method (2DDCt method), considering the
Fig. 5. (a) Morphology/mineralisation (SEMmicrographs) of BM-MSCs and their (b) ALP activity after 7, 14 and 21 days of culture in the presence of PLLA and PLLA-BBG-Sr, in
basal (basal) or osteogenic medium (osteo). ALP results are expressed as mean ± standard deviation with n = 3 for each datapoint. The data was analysed by non-parametric
statistics: Kruskal-Wallis test, followed by a Dunn’s Multiple Comparison test. **(p < 0.01); *(p < 0.05). The significance is in relation to cells cultured on PLLA (in the absence of
BBG-Sr glass particles) under the same culture conditions.
J.S. Fernandes et al. / Acta Biomaterialia 44 (2016) 168–177 175PLLA (basal medium) as calibrator for PLLA (osteogenic medium)
and PLLA-BBG-Sr (basal medium) as calibrator for PLLA-BBG-Sr
(osteogenic medium). Commonly, Alpl acts as early marker of the
osteoblastic phenotype. This gene expression level is known to
increase with the progression of osteoblastic differentiation [54].
According to the gene expression data (Fig. 6a) there is a significant
up-regulation of Alpl in the BM-MSCs cultured onto PLLA-BBG-Sr
membranes at 14 and 21 days of culture in relation to BM-MSCs
cultured onto PLLA membranes (all under osteogenic medium).
Again, Ren et al. found the same Alpl gene up regulated in MC3T3
cells cultured in PCL-SrBG membranes, but only after 21 days of
culture. These observations are consistent with the quantification
of the ALP activity (Fig. 5b), in which there was a significantly
higher activity for the BM-MSCs cultured onto PLLA-BBG-Sr (under
osteogenic medium) after 14 days of culture, when compared with
the cells cultured onto PLLA [48,49]. Regarding the maturation and
mineralisation phase, we investigated the expression of the genes
that encode two non-collagenous proteins present with the ECM
of bone, e.g. Spp1 and Bglap. Spp1 is a protein found in bone, teeth,
kidneys and epithelial lining tissue; consequently, Spp1 cannot be
considered bone-specific, although it is associated to bone related
functions [8,46]. The Spp1 gene expression results (Fig. 6b) showed
that at 14 days of culture, BM-MSCs cultured on PLLA presents a
high Spp1 expression, which might be related with their important
functions in cell adhesion, migration and survival [54]. The fact
that Spp1 expression is significantly higher when cultured on PLLA
membranes might be a result of proliferation and cell spreading
processes. On the other hand, Bglap, which is the second most
abundant protein present in bone, is exclusively secreted byosteoblastic cells at the last stage of maturation [46,54]. When
cultured on PLLA-BBG-Sr membranes, Bglap expression (Fig. 6c) is
significantly higher in relation to the basal medium for 14 and
21 days of culture. This suggests that the combined effect of the
osteogenic factors and the dissolution products might be enhanc-
ing Bglap gene expression, which may be an indicator of osteoblas-
tic differentiation. This data is in accordance with the report of
Strobel et al. [55] showing that BM-MSCs, after 14 days of exposure
to cell culture medium containing nanoparticles of Sr-substituted
Bioglass, increased their Bglap expression. Finally, Sp7 is a well-
characterised osteoblast specific gene and it is associated with
the regulation of numerous other genes (e.g. osteocalcin, osteopon-
tin, bone sialoprotein), and is acknowledged as a late bone marker
that plays a key role in the differentiation of preosteoblasts into
fully functioning osteoblasts [8,54]. Our data at day 21 registered
an increase of Sp7 gene expression in the BM-MSCs cultured on
PLLA-BBG-Sr membranes (under osteogenic medium) in relation
to the same cells cultured on the same membranes but under basal
medium, as well as the cells cultured onto PLLA (under osteogenic
and basal medium). These observations are consistent with the
overexpression of the other monitored gene Alpl and their protein
expression (ALP) for PLLA-BBG-Sr membrane [56]. In fact, Isaac
et al. [57] demonstrated that the addition of strontium to bioactive
glass particles resulted in a significant up-regulation of Runx2 and
Osterix of osteoblastic cells. In summary, the detected overexpres-
sion of Alpl, Bglap and Sp7 genes in cells cultured onto PLLA-BBG-Sr
membranes show that the incorporation of BBG-Sr glass particles
into the PLLA membranes promotes the osteogenic differentiation
of BM-MSCs [48].
Fig. 6. Relative gene expression profile of BM-MSCs cultured onto PLLA and PLLA-BBG-Sr membranes during 14 and 21 days. Selected genes: (a) Alpl, osteogenic
mineralisation initiator; (b) Spp1 and (c) Bglap, extracellular matrix; and (d) Sp7, transcription factors. The transcripts’ expression data were normalised against the
housekeeping gene Gapdh and the quantification performed according to the Livak method (2DDCt method). For each timepoint it was used: the calibrator PLLA (in basal
medium) for the experiments with PLLA (in osteogenic medium); and the calibrator PLLA-BBG-Sr (in basal medium) for the experiments with PLLA-BBG-Sr (in osteogenic
medium). In all the cases the calibrator is represented as a dashed line (threshold = 1). The results are expressed as mean ± standard deviation with n = 3 for each bar. The data
was analysed by non-parametric statistics: Kruskal-Wallis test, followed by a Dunn’s Multiple Comparison test and differences were considered: ***p < 0.001; **p < 0.01; and
*p < 0.05. a denotes significant differences in relation to cells cultured in basal medium (PLLA or PLLA-BBG-Sr); b denotes significant differences in relation to cell cultured
onto PLLA in osteogenic medium.
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Bioactive membranes of PLLA-BBG-Sr composites were success-
fully prepared using electrospinning. The lCT data evidenced that
BBG-Sr microparticles were homogeneously incorporated into the
fibres and the membrane structure. Our data indicated that, the
addition of BBG-Sr into the PLLA matrix improved the in vitrowater
uptake and degradability of the membranes. Moreover, the incor-
poration of the BBG-Sr microparticles improved the mechanical
properties of the membranes, namely in their Young modulus
and tensile strength. The in vitro biological evaluation confirmed
that both PLLA and PLLA-BBG-Sr membranes are able to promote
the attachment of BM-MSCs, without any cytotoxic effects.
Furthermore, the addition of BBG-Sr microparticles to the PLLA
membranes increased the ALP activity (under osteogenic condi-
tions), as well as the BM-MSCs osteogenic differentiation as shown
by up-regulation of Alpl, Sp7 and Bglap gene expression in vitro. The
present work suggests that the composite of PLLA membranes and
BBG-Sr microparticles can be used as a strategy to prepare
bioactive composite membranes for bone regeneration.Acknowledgements
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